569 related articles for article (PubMed ID: 28060743)
1. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.
González N; Prieto I; Del Puerto-Nevado L; Portal-Nuñez S; Ardura JA; Corton M; Fernández-Fernández B; Aguilera O; Gomez-Guerrero C; Mas S; Moreno JA; Ruiz-Ortega M; Sanz AB; Sanchez-Niño MD; Rojo F; Vivanco F; Esbrit P; Ayuso C; Alvarez-Llamas G; Egido J; García-Foncillas J; Ortiz A;
Oncotarget; 2017 Mar; 8(11):18456-18485. PubMed ID: 28060743
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus and hyperglycemia control on the risk of colorectal adenomatous polyps: a retrospective cohort study.
Budzynska K; Passerman D; White-Perkins D; Rees DA; Xu J; Lamerato L; Schooley S
BMC Fam Pract; 2018 Aug; 19(1):145. PubMed ID: 30157768
[TBL] [Abstract][Full Text] [Related]
3. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer.
Dimberg J; Shamoun L; Landerholm K; Wågsäter D
World J Gastroenterol; 2022 May; 28(19):2148-2151. PubMed ID: 35664033
[TBL] [Abstract][Full Text] [Related]
4. Metformin and Colorectal Cancer - A Systematic Review.
Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
[TBL] [Abstract][Full Text] [Related]
6. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer.
Huang CW; Sun LC; Shih YL; Tsai HL; Chen CW; Yeh YS; Ma CJ; Huang CJ; Wang JY
World J Surg Oncol; 2012 May; 10():76. PubMed ID: 22553992
[TBL] [Abstract][Full Text] [Related]
7. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
[TBL] [Abstract][Full Text] [Related]
8. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
9. Metformin and colorectal cancer risk in diabetic patients.
Ioannou GN; Boyko EJ
Diabetes Care; 2011 Oct; 34(10):2336-7. PubMed ID: 21949227
[No Abstract] [Full Text] [Related]
10. Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study.
Dash C; Palmer JR; Boggs DA; Rosenberg L; Adams-Campbell LL
Am J Epidemiol; 2014 Jan; 179(1):112-9. PubMed ID: 24091887
[TBL] [Abstract][Full Text] [Related]
11. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
Wang Q; Shi M
Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
[TBL] [Abstract][Full Text] [Related]
12. Metformin usage and the risk of colorectal cancer: a national cohort study.
Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
[TBL] [Abstract][Full Text] [Related]
13. Metformin: A Salutary Candidate for Colorectal Cancer Treatment in Patients with Diabetes.
Samuel VP; Dahiya R; Singh Y; Gupta G; Sah SK; Gubbiyappa SK; Chellappan DK; Dua K
J Environ Pathol Toxicol Oncol; 2019; 38(2):133-141. PubMed ID: 31679276
[TBL] [Abstract][Full Text] [Related]
14. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.
Peeters PJ; Bazelier MT; Leufkens HG; de Vries F; De Bruin ML
Diabetes Care; 2015 Mar; 38(3):495-502. PubMed ID: 25552419
[TBL] [Abstract][Full Text] [Related]
15. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
16. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
[TBL] [Abstract][Full Text] [Related]
17. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
[TBL] [Abstract][Full Text] [Related]
18. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
19. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH
Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944
[TBL] [Abstract][Full Text] [Related]
20. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
